Food and Drug Administration Grants

Food and Drug Administration · Amount varies

This is a forecasted FDA research opportunity (U01, no clinical trials) to use real-world data and algorithmic analysis to assess post-market clinical outcomes for patients switching between therapeutically equivalent complex generic drugs and their reference drugs. Eligibility, award amounts, and deadlines are not yet announced; such cooperative agreements generally support universities and research institutions with relevant data and pharmacology expertise. Review the official notice when published to confirm requirements.

Food and Drug Administration · Amount varies

This is a forecasted (not yet open) Food and Drug Administration cooperative agreement to strengthen antibiotic resistance surveillance (NARMS) in retail food specimens. Eligibility, award amount, and deadline are not yet published; cooperative agreements of this kind typically go to state/public health agencies and research institutions. Check the full notice before planning to apply.

Food and Drug Administration · Amount varies

This is a forecasted FDA Office of Minority Health and Health Equity opportunity (U01 cooperative agreement, no clinical trials allowed) to fund health equity innovation projects. It will likely target research institutions and organizations with health equity research capacity. Eligibility, funding amounts, and deadlines are not yet available; check the full announcement before applying.

Food and Drug Administration · Amount varies

This is a forecasted FDA opportunity (U01 cooperative agreement, clinical trial optional) to develop PBPK model-based mechanistic in vitro-in vivo correlations for long-acting injectable suspensions and implants. It is a specialized pharmaceutical-sciences topic likely limited to research institutions and investigators with relevant modeling expertise. Eligibility, funding amounts, and deadlines are not yet available; review the full announcement before applying.

Food and Drug Administration · Amount varies

This is a forecasted FDA research opportunity (R01) supporting development of drugs for minor uses and minor animal species. The full announcement has not been posted, so eligibility, funding amounts, and deadlines are not yet available; R01 awards typically go to research institutions and investigators. Wait for the formal NOFO for specific requirements.

Food and Drug Administration · Amount varies

This is a forecasted FDA opportunity supporting Critical Path public-private partnerships, with clinical trials optional. The full announcement has not been posted, so eligibility, funding amounts, and deadlines are not yet available. These programs typically involve research institutions, nonprofits, and consortia; wait for the formal NOFO for specific requirements.

Food and Drug Administration · Amount varies

A forecasted (not yet open) FDA opportunity (U01, clinical trial required) to fund research evaluating the cutaneous pharmacokinetics of topical drug products using pharmacokinetic tomography. It is aimed at research institutions and investigators with expertise in dermatological pharmacokinetics and the capacity to run a required clinical study. Specific eligibility, funding amounts, and deadlines have not yet been posted.

Food and Drug Administration · Amount varies

This is a forecasted FDA opportunity (Phase 2) focused on data standards for tobacco research and scientific review. Eligibility, funding amount, and deadline have not yet been published, so it is not open for application. Awards like this typically target research organizations or institutions with relevant data-standards and regulatory science expertise; review the full notice when it is released for specific eligibility.

Food and Drug Administration · Amount varies

This FDA/NIH-style R01 opportunity (clinical trial required) funds clinical studies of orphan products addressing unmet needs in rare diseases, typically intended for research institutions and clinical investigators rather than general nonprofits or businesses. Eligibility details, award amounts, and deadlines are not provided in this forecast-stage listing, so applicants should watch for the full funding announcement.

Food and Drug Administration · Amount varies

This is a forecasted (not yet open) FDA R01 research grant to support clinical trials addressing unmet needs in rare neurodegenerative diseases; conducting a clinical trial is required under this opportunity. It is intended for research institutions and investigators able to run clinical trials, not general nonprofits or businesses. Eligibility details, funding amounts, and deadlines have not been published yet; watch for the full announcement before applying.

Food and Drug Administration · Amount varies

This is a forecasted (not yet open) FDA cooperative agreement (U01) supporting activities related to analgesics, anesthetics, and addiction, with clinical trials allowed. It is aimed at research institutions and investigators in these areas rather than general nonprofits or businesses. Specific eligibility, funding amounts, and deadlines have not yet been published; monitor for the full announcement before applying.

Food and Drug Administration · Amount varies

This is a forecasted FDA opportunity to support an Animal Food Regulatory Program Alliance, which strengthens coordination of animal-food (feed) regulatory programs. Awards of this type typically go to state agencies, regulatory associations, and similar partner organizations rather than to individuals or general businesses. Eligibility, funding amounts, and deadlines are not yet posted, so review the official notice when available.

Food and Drug Administration · Amount varies

This is a forecasted FDA cooperative agreement (U01) to expand public education on the risks of skin-lightening products; clinical trials are not allowed. Awards of this kind generally go to nonprofits, universities, and public-health organizations with relevant outreach capacity rather than to individuals or general businesses. Eligibility, funding amounts, and deadlines are not yet posted, so review the official notice before applying.

Food and Drug Administration · Amount varies

This is a forecasted (not yet open) FDA cooperative agreement (U18) to support a Center for Research on Complex Generics, with clinical trials optional. Eligibility, funding amounts, and deadlines are not yet published; based on the title it targets research organizations working on generic drug development. Review the official FDA/NIH listing for full terms once it is posted.